• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮胫神经刺激治疗膀胱过度活动症症状六次后的疗效及性别特异性结果。

Efficacy and sex-specific outcomes after six episodes of percutaneous tibial nerve stimulation treatment on overactive bladder syndrome symptoms.

作者信息

Perez Martinez Carlos, Palacios-Galicia Jose Luis, Vargas-Diaz Irma B, Munoz Alvaro, Cruz Yolanda

机构信息

Doctorado en Ciencias Biológicas, Universidad Autónoma de Tlaxcala, Tlaxcala, Tlaxcala, Mexico.

Centro de Urologia Avanzada (CURA), Delicias, Chihuahua, Mexico.

出版信息

Front Urol. 2024 Feb 19;4:1352701. doi: 10.3389/fruro.2024.1352701. eCollection 2024.

DOI:10.3389/fruro.2024.1352701
PMID:40777086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12327289/
Abstract

OBJECTIVE

This study aimed to investigate the efficacy of six episodes of percutaneous tibial nerve stimulation (PTNS) treatment for overactive bladder (OAB) symptoms in men and women and to determine the duration of the effects over a 6-month period.

METHODS

Women and men with OAB symptoms participated in the study, which was conducted in accordance with an approved ethical protocol (ISRCTN15733799). Patients underwent six 30-min PTNS sessions, twice per week. The symptoms of OAB were assessed using a voiding diary, the short form of the Overactive Bladder Symptom Score questionnaire (OAB-q SF), and the Patient Perception of Bladder Condition (PPBC), which were self-completed by patients before and after treatment (24 h and at 1, 3, and 6 months). The outcome data were compared for sex and time points using two-way ANOVA for repeated measures.

RESULTS

PTNS treatment significantly improved the OAB symptoms and quality of life in men and women. PTNS increased the voided volume ( < 0.05) and decreased the frequency of voiding, nocturia, and urgency at 24 h and up to 6 months ( < 0.001). The OABq-SF and PPBC scores were significantly decreased after PTNS ( < 0.001). Urgency was greater in men than in women. The duration of PTNS clinical success on frequency and the perception of improvement in quality of life were greater in women than in men.

CONCLUSION

The clinical effects of six sessions of PTNS strongly suggest its potential for shortening, from the standard 12 sessions, to effectively alleviate symptoms of OAB. This therapeutic procedure would reduce both the time and economic costs of OAB treatment.

摘要

目的

本研究旨在调查六次经皮胫神经刺激(PTNS)治疗对男性和女性膀胱过度活动症(OAB)症状的疗效,并确定6个月内效果的持续时间。

方法

有OAB症状的男性和女性参与了本研究,该研究按照批准的伦理方案(ISRCTN15733799)进行。患者每周接受两次,每次30分钟的PTNS治疗,共六次。使用排尿日记、膀胱过度活动症症状评分问卷简表(OAB-q SF)和患者膀胱状况感知(PPBC)对OAB症状进行评估,患者在治疗前和治疗后(24小时以及1、3和6个月)自行填写。使用重复测量的双向方差分析对性别和时间点的结果数据进行比较。

结果

PTNS治疗显著改善了男性和女性的OAB症状及生活质量。PTNS增加了排尿量(<0.05),并在24小时至6个月内降低了排尿频率、夜尿次数和尿急程度(<0.001)。PTNS治疗后,OAB-q SF和PPBC评分显著降低(<0.001)。男性的尿急程度高于女性。PTNS在频率方面临床成功的持续时间以及生活质量改善的感知在女性中比男性更长。

结论

六次PTNS治疗的临床效果强烈表明其有可能从标准的12次缩短疗程,以有效缓解OAB症状。这种治疗方法将减少OAB治疗的时间和经济成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/12327289/f69149a67737/fruro-04-1352701-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/12327289/77d1d6cdd6f6/fruro-04-1352701-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/12327289/31e7e04b3fb7/fruro-04-1352701-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/12327289/9f4a22f32232/fruro-04-1352701-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/12327289/f69149a67737/fruro-04-1352701-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/12327289/77d1d6cdd6f6/fruro-04-1352701-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/12327289/31e7e04b3fb7/fruro-04-1352701-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/12327289/9f4a22f32232/fruro-04-1352701-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/12327289/f69149a67737/fruro-04-1352701-g004.jpg

相似文献

1
Efficacy and sex-specific outcomes after six episodes of percutaneous tibial nerve stimulation treatment on overactive bladder syndrome symptoms.经皮胫神经刺激治疗膀胱过度活动症症状六次后的疗效及性别特异性结果。
Front Urol. 2024 Feb 19;4:1352701. doi: 10.3389/fruro.2024.1352701. eCollection 2024.
2
Impact of Weekly Application Frequency on the Efficacy of Tibial Nerve Stimulation Therapy in the Treatment of Overactive Bladder.每周应用频率对胫神经刺激疗法治疗膀胱过度活动症疗效的影响。
Int Urogynecol J. 2025 Jul 16. doi: 10.1007/s00192-025-06217-8.
3
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms: FUTURE, a superiority RCT and economic evaluation.侵入性尿动力学检查在难治性膀胱过度活动症女性患者管理中的应用:FUTURE,一项优效性随机对照试验及经济学评估
Health Technol Assess. 2025 Jul;29(27):1-139. doi: 10.3310/UKYW4923.
4
Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.抗胆碱能药物与非药物活性疗法治疗成人非神经源性膀胱过度活动症
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD003193. doi: 10.1002/14651858.CD003193.pub4.
5
Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.经皮和经皮胫后神经刺激治疗特发性膀胱过度活动症和间质性膀胱炎/疼痛性膀胱综合征的疗效:一项系统评价和荟萃分析。
Neurourol Urodyn. 2022 Feb;41(2):539-551. doi: 10.1002/nau.24864. Epub 2022 Jan 15.
6
Bladder training for treating overactive bladder in adults.膀胱训练治疗成人膀胱过度活动症。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD013571. doi: 10.1002/14651858.CD013571.pub2.
7
Transvaginal Electrical Stimulation for Treatment of Overactive Bladder Without Incontinence: A Pilot Cross-Over Clinical Trial.经阴道电刺激治疗无尿失禁的膀胱过度活动症:一项前瞻性交叉临床试验
Neurourol Urodyn. 2025 Jun;44(5):977-986. doi: 10.1002/nau.70034. Epub 2025 Mar 26.
8
Association of catechol-O-methyltransferase genetic polymorphism with neuromodulation treatment response in women with fecal or urinary incontinence.儿茶酚-O-甲基转移酶基因多态性与粪失禁或尿失禁女性神经调节治疗反应的关联
Am J Obstet Gynecol. 2025 Sep;233(3):178.e1-178.e10. doi: 10.1016/j.ajog.2025.03.007. Epub 2025 Mar 10.
9
Botulinum toxin injections for adults with overactive bladder syndrome.肉毒杆菌毒素注射治疗成人膀胱过度活动症
Cochrane Database Syst Rev. 2011 Dec 7(12):CD005493. doi: 10.1002/14651858.CD005493.pub3.
10
A First-In-Human Feasibility Study of a New Implantable Tibial Nerve Stimulator for Overactive Bladder Syndrome.一种用于膀胱过度活动症的新型可植入胫神经刺激器的首次人体可行性研究。
Neuromodulation. 2025 Jul;28(5):832-839. doi: 10.1016/j.neurom.2025.01.013. Epub 2025 Mar 1.

本文引用的文献

1
Patient-tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms.个体化医疗和胫神经神经调节治疗膀胱过度活动症患者。
Neurourol Urodyn. 2022 Feb;41(2):679-684. doi: 10.1002/nau.24873. Epub 2022 Jan 12.
2
Influence of patient sex on the effectiveness of sacral neuromodulation: A cohort study from China.患者性别对骶神经调节有效性的影响:一项来自中国的队列研究。
Int J Surg. 2020 Dec;84:13-17. doi: 10.1016/j.ijsu.2020.10.007. Epub 2020 Oct 17.
3
Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis.
经皮胫神经刺激治疗膀胱过度活动症:系统评价和荟萃分析。
Int Urogynecol J. 2020 Dec;31(12):2457-2471. doi: 10.1007/s00192-020-04429-8. Epub 2020 Jul 17.
4
Percutaneous tibial nerve stimulation maintenance therapy for overactive bladder in women: long-term success rates and adherence.经皮胫神经刺激维持治疗女性膀胱过度活动症:长期成功率和依从性。
Int Urogynecol J. 2021 Mar;32(3):617-625. doi: 10.1007/s00192-020-04325-1. Epub 2020 Jun 22.
5
8 versus 12 weeks of percutaneous tibial nerve stimulation and response predictors for overactive bladder.8 周与 12 周经皮胫神经刺激治疗逼尿肌过度活动症及疗效预测因素。
Int Urogynecol J. 2020 May;31(5):905-914. doi: 10.1007/s00192-019-04191-6. Epub 2020 Jan 11.
6
Posterior tibial nerve stimulation for overactive bladder-techniques and efficacy.胫后神经刺激治疗膀胱过度活动症——技术与疗效
Int Urogynecol J. 2020 May;31(5):865-870. doi: 10.1007/s00192-019-04186-3. Epub 2019 Dec 18.
7
Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients.超过 400 例患者的经皮胫神经刺激的长期真实世界依从性。
Neurourol Urodyn. 2020 Feb;39(2):702-706. doi: 10.1002/nau.24254. Epub 2019 Dec 17.
8
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019.成人过度活动膀胱(非神经性)的诊断和治疗:2019 年 AUA/SUFU 指南修订版。
J Urol. 2019 Sep;202(3):558-563. doi: 10.1097/JU.0000000000000309. Epub 2019 Aug 8.
9
The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction.国际尿控协会(ICS)关于成人男性下尿路和盆底症状及功能障碍术语的报告。
Neurourol Urodyn. 2019 Feb;38(2):433-477. doi: 10.1002/nau.23897. Epub 2019 Jan 25.
10
The economic burden of overactive bladder in the United States: A systematic literature review.美国过度膀胱症的经济负担:系统文献回顾。
Neurourol Urodyn. 2018 Apr;37(4):1241-1249. doi: 10.1002/nau.23477. Epub 2018 Jan 13.